Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Download
  • Rewards
  • Help
  • TigerAI
  • Institution
    • Wealth and asset manager
    • Proprietary trading institutions
    • Introducing brokers
    • Third-party service provider
    • Esop
  • About
    • About us
    • Newsroom
    • Awards
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Trade Technology Pte. Ltd.

Xenon Pharmaceuticals

38.02
-0.9100-2.34%
Post-market: 37.28-0.7400-1.95%19:32 EDT
Volume:1.94M
Turnover:73.46M
Market Cap:3.67B
PE:-8.08
High:39.10
Open:39.10
Low:37.26
Close:38.93
52wk High:72.66
52wk Low:36.07
Shares:96.64M
Float Shares:95.45M
Volume Ratio:0.70
T/O Rate:2.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.7061
EPS(LYR):-4.3646
ROE:-43.62%
ROA:-28.02%
PB:2.96
PE(LYR):-8.71

Loading ...

OverviewCompanyNewsFilings

Xenon (XENE) Gets a Buy from Stifel Nicolaus

TIPRANKS
·
Apr 28

Is Xenon Pharmaceuticals (XENE) Attractive After Recent Pullback And Strong One Year Rally

Simply Wall St.
·
Apr 25

What Xenon Pharmaceuticals (XENE)'s Positive Phase 3 X-TOLE2 Epilepsy Data Means For Shareholders

Simply Wall St.
·
Apr 22

Analysts Are Bullish on Top Healthcare Stocks: Xenon (XENE), Biogen (BIIB)

TIPRANKS
·
Apr 20

Xenon Pharmaceuticals presents data from Phase 3 X-TOLE2 study

TIPRANKS
·
Apr 20

Xenon says Phase 3 X-TOLE2 trial shows azetukalner cuts monthly seizures 53%

Reuters
·
Apr 20

Assessing Xenon Pharmaceuticals (XENE) Valuation After Strong Recent Share Price Momentum

Simply Wall St.
·
Apr 18

Xenon Pharmaceuticals to present at Bloom Burton healthcare investor conference

Reuters
·
Apr 15

Xenon expands 2025 inducement equity plan share reserve to 1,175,000 shares

Reuters
·
Apr 14

Xenon highlights Phase 3 X-TOLE2 azetukalner data in focal onset seizures at AAN 2026

Reuters
·
Apr 07

Analyst Rate

Buy
Buy
95.00%
Hold
5.00%
Sell
0.00%

Corporate Actions

Financial Report Announcement
Aug 06, 2026 Post-Mkt
Financial Report Announcement
May 07, 2026 Post-Mkt
Financial Report Announcement
Feb 26, 2026 Post-Mkt
Financial Report Announcement
Nov 03, 2025 Post-Mkt
Financial Report Announcement
Aug 11, 2025 Post-Mkt

Dividend History

no data

No relevant data is available

Valuation Analysis

-8.08
Current
-16.76
Sector Average
98.78%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-8.08
Maximum
-8.86
+1 STD
-11.82
Minimum
-31.86
-1 STD
-21.70
Average
-16.76

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Trade Technology Pte. Ltd.
Email Address:
dpo@itiger.com
User Agreement|Privacy Policy

Copyright © Tiger Trade Technology Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.